Life

Health, science, climate, and society-focused reporting.

Broad Institute to Receive $1 Billion for Bipolar Disorder and Schizophrenia Research

The Broad Institute of MIT and Harvard is set to receive a significant financial boost of $1 billion aimed at advancing research into bipolar disorder and schizophrenia.

Editorial Staff Mar 20

Life

Urgent Reforms Needed for No Surprises Act to Prevent Financial Strain

Experts James Gelfand and Patricia Kelmar highlight the critical need for Congress to amend the No Surprises Act to safeguard patients and employers from potential financial crises.

Editorial Staff Mar 20

Life

Implications of the Farm Bill on Tobacco and Public Health Initiatives

The farm bill's potential support for tobacco farming raises concerns about its alignment with public health objectives, particularly regarding MAHA's stance.

Editorial Staff Mar 20

Life

Former FDA Commissioner Highlights Political Pressures Impacting Agency's Role

Robert Califf, the former FDA commissioner, raises concerns about the increasing political influence on the FDA during the Trump administration, affecting decision-making processes.

Editorial Staff Mar 20

Life

U.S. District Judge to Vacate Kennedy's Standards on Gender-Affirming Care

A ruling by a U.S. district judge is expected to vacate Kennedy's declaration regarding the medical standards for gender-affirming care for young trans individuals.

Editorial Staff Mar 20

Life

China's Drug Development Surge: Implications for U.S. Biotech Infrastructure

China's rapid advancements in drug development raise critical questions for U.S. biotech infrastructure. Analyzing the systems and capacity implications is essential for strategic positioning.

Editorial Staff Mar 19

Life

Autism Committee Initiates Congressional Influence Efforts

A coalition of autism researchers has begun efforts to engage with Congress and shape the research priorities of private organizations.

Editorial Staff Mar 19

Life

Trump Administration's Drug Pricing Strategy Faces Scrutiny Ahead of Midterms

The Trump administration aims to leverage its drug pricing initiatives, including TrumpRx, as a key component in the upcoming midterm elections, though expectations are being moderated.

Editorial Staff Mar 19

Life

HHS Public Health Policy Actions Under the Trump Administration 2025-2026

A detailed timeline outlines the public health policy actions undertaken by HHS during the Trump administration from 2025 to 2026, highlighting key dates and impacts.

Editorial Staff Mar 19

Life

Tracking State Actions on Medicaid Postpartum Coverage Extensions

This report provides an overview of state-level initiatives aimed at extending Medicaid postpartum coverage, including various waivers and legislative measures.

Editorial Staff Mar 19

Life

Medicare Telehealth Coverage: Current Status and Future Implications

Congress has extended several pandemic-era flexibilities regarding Medicare telehealth coverage, yet most remain temporary, raising questions about long-term infrastructure.

Editorial Staff Mar 19

Life

Democrats Outline Health Care System Overhaul Ahead of Midterms

Ahead of the midterm elections, Democrats are formulating a comprehensive strategy for health care reform, which could significantly impact system architecture and service delivery.

Editorial Staff Mar 19

Life

U.S. Approval Granted for Novo Nordisk's High-Dose Wegovy

The U.S. has approved a high-dose formulation of Wegovy, an injectable drug from Novo Nordisk designed for obesity treatment, indicating a potential shift in treatment protocols.

Editorial Staff Mar 19

Life

Eli Lilly's 'triple-G' Drug Demonstrates Potency Amid Concerns

Eli Lilly's 'triple-G' drug has shown significant potency, while advancements in In-vivo CAR-T therapy are moving closer to clinical application, raising important considerations.

Editorial Staff Mar 19

Life

Apple Watch Utilized in Clinical Trial for Parkinson’s Drug

A biotech firm is integrating Apple Watch technology into its clinical trial for a Parkinson's drug, aiming to enhance data collection and patient monitoring.

Editorial Staff Mar 19

Life

Potential Undercount of Covid Deaths Raises Concerns

Recent discussions suggest the U.S. may have underreported Covid-19 deaths by up to 155,000, highlighting significant implications for public health data accuracy and response strategies.

Editorial Staff Mar 19

Life

Eli Lilly's Investigational Drug Demonstrates Efficacy in Diabetes Management

In a late-stage study, Eli Lilly's investigational drug has shown significant reductions in blood sugar levels and weight among diabetes patients, indicating potential shifts in treatment paradigms.

Editorial Staff Mar 19

Life

Eli Lilly's Investigational Drug Shows Promising Results in Diabetes Management

In a late-stage trial, Eli Lilly's investigational drug demonstrated substantial reductions in blood sugar levels and weight among diabetes patients, indicating potential advancements in diabetes treatment.

Editorial Staff Mar 19

Life

FDA Regulatory Landscape Post-Prasad: Implications for Rare-Disease Drug Approvals

The impending departure of Vinay Prasad raises questions about potential shifts in the FDA's regulatory framework for rare-disease drugs, impacting drugmakers and market dynamics.

Editorial Staff Mar 19

Life

KFF Survey Highlights Cost and Coverage Changes for ACA Marketplace Enrollees in 2025

A recent KFF survey reveals significant cost concerns and coverage changes among ACA Marketplace enrollees in 2025, following the end of enhanced benefits.

Editorial Staff Mar 19